Examines treatment efficacy using glucocorticoid receptor antagonists in cancer patients, suggesting potential benefits.
Embodiments are directed to kits and methods of treating a breast cancer patient with a glucocorticoid receptor antagonist with or without an anticancer agent or compound after the patient has been determined to be susceptible to treatment with the glucocorticoid receptor antagonist.
No takes yet. Share an insight, caveat, or question.
Conzen et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: